<?xml version="1.0" encoding="UTF-8"?>
<p id="Par46">Likewise, individuals with hypertension would have a higher expression of ACE2 secondary to the use of RAAS inhibitors, which would potentially increase the susceptibility to infection by SARS-CoV-2. In animal models, the use of these drugs can generate an upregulation effect, producing a greater number of ACE2 receptors in the myocardium and lung cells, inferring a facilitated entry of the virus into the host cells consequently enhancing SARS-CoV-2 virulence [
 <xref ref-type="bibr" rid="CR30">30</xref>, 
 <xref ref-type="bibr" rid="CR35">35</xref>]. Nonetheless, evidences initially deducing that the use of RAAS blockers during the COVID-19 might be deleterious were not confirmed.
</p>
